Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Tropical Medicine & International Health : TM & IH|November 27, 2015
Cost-optimization in the treatment of multidrug resistant tuberculosis in NigeriaBaba Maiyaki Musa, Denny John, Abdulrazaq G Habib, et al.
Journal of Managed Care & Specialty Pharmacy|March 3, 2022
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory settingNick Jovanoski, Andreas Kuznik, Ursula Becker, et al.
Tropical Doctor|January 7, 2012
Medical male circumcision for HIV/AIDS prevention in Uganda - the cost of disposable versus re-usable circumcision kitsAndreas Kuznik, Mohammed Lamorde, Denis Bbaale Sekavuga, et al.
Clinical Therapeutics|March 14, 2009
Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) studyC Daniel Mullins, Gail B Rattinger, Andreas Kuznik, et al.
The American Journal of Geriatric Pharmacotherapy|October 25, 2011
Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatinJason P Swindle, Jesse Potash, Mahesh Kulakodlu, et al.
Postgraduate Medicine|September 24, 2010
Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged ≥ 65 years by lipid-lowering medication use statusSean D Candrilli, Andreas Kuznik, Philip M Mendys, et al.
Clinical Therapeutics|September 30, 2011
The value of atorvastatin over the product life cycle in the United StatesMichael Grabner, Wallace Johnson, Abdulla M Abdulhalim, et al.
Surgical Infections|June 24, 2008
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infectionsJohn Edelsberg, Ariel Berger, Scott Schell, et al.
American Journal of Therapeutics|September 23, 2009
Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterolHerbert D Aronow, Gregory Hess, Jerrold Hill, et al.
Health Policy and Planning|September 26, 2018
Estimating the cost and cost-effectiveness for obstetric fistula repair in hospitals in Uganda: a low income countryIsabella Epiu, Godfrey Alia, John Mukisa, et al.
Pageof 8